News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>DBS Lowers XPENG-W TP to HKD118; 1Q25 Results Beat
DBS Group Research's report wrote that XPENG-W (09868.HK)(XPEV.US)'s 1Q25 results topped street consensus, with revenue swelling 142% YoY, gross margin hiking to 15.6%, and...
Reset
Send
The window will close in 5 seconds
<Research>DBS Lowers XPENG-W TP to HKD118; 1Q25 Results Beat
Close
Recommend
9
Positive
24
Negative
7
 
SHORT SELL
 
STOCK INFO

DBS Group Research's report wrote that XPENG-W (09868.HK)  +0.200 (+0.265%)    Short selling $297.22M; Ratio 23.647%   (XPEV.US)      's 1Q25 results topped street consensus, with revenue swelling 142% YoY, gross margin hiking to 15.6%, and the non-GAAP net loss narrowing to RMB430 million.

Thanks to improvements in product mix and costs, the automotive margins for 2025 and 2026 were estimated to hit 12% and 14%, respectively, ahead of the 8.3% forecast for 2024, with estimated sales of approximately 400,000 and 538,000 units.

Related NewsCCBI Adds XPeng (XPEV.US) TP to US$25.6, Rating Outperform
Given XPeng's 1Q25 results beat, the broker revised down its net loss forecast for 2025 by about 12%. However, considering the impact of tariffs, it lowered the target price from HKD126 to HKD118, maintaining a Buy rating.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-05-27 16:25.) (Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)

AASTOCKS Financial News
Website: www.aastocks.com
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.